CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 162 enrolled
Drug / intervention
IV acetaminophen +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03553498
NCT03553498Phase 3Completed
CompareCT.gov

Randomized Clinical Trial of IV Acetaminophen as an Adjuvant Analgesic to IV Hydromorphone for Treatment of Acute Severe Pain in Non-Elderly Emergency Department Patients

Albert Einstein College of Medicine·interventional·Posted Jun 12, 2018·Updated Mar 2, 2022

In Brief

A Phase 3 clinical trial evaluating IV acetaminophen, IV placebo, and 1 other intervention for Acute Pain. Completed, enrolled 162 participants across 1 site.

Detailed Summary

The goal of this randomized clinical trial is to compare the analgesic efficacy and side effect profile of IV acetaminophen as an analgesic adjunctive medication to IV hydromorphone for the treatment of acute pain experienced by patients in the Emergency Department (ED).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedJun 12, 2018
Enrollment StartNov 27, 2018
Primary CompletionMay 15, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.1 years ago

Interventions

IV acetaminophendrug

acetaminophen given intravenously

IV placebodrug

given intravenously

hydromorphonedrug

hydromorphone given intravenously